Sernova Biotherapeutics Inc SVA.TO
TSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -25.33% | -46.48% | -49.09% | -95.62% | -98.34% |
| Total Receivables | -95.94% | -72.61% | -64.09% | -59.09% | -46.63% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 94.19% | -24.94% | -83.82% | -15.67% | -78.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -27.06% | -46.81% | -59.98% | -91.97% | -91.99% |
|
|
|||||
| Total Current Assets | -27.06% | -46.81% | -59.98% | -91.97% | -91.99% |
| Net Property, Plant & Equipment | -97.63% | -98.78% | -98.20% | -97.89% | -79.20% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 6.66% | -0.56% | -0.19% |
| Total Assets | -59.49% | -59.79% | -64.89% | -89.91% | -87.81% |
|
|
|||||
| Total Accounts Payable | -74.41% | -73.06% | -3.18% | 1.88% | 4.01% |
| Total Accrued Expenses | 349.13% | 344.28% | 548.25% | 26.61% | 85.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3,806.56% | 1,931.72% | -- | -- | -34.81% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -51.22% | -52.35% | 32.48% | 23.20% | 24.67% |
|
|
|||||
| Total Current Liabilities | -51.22% | -52.35% | 32.48% | 23.20% | 24.67% |
| Long-Term Debt | -91.74% | -71.16% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -93.45% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -52.79% | -53.77% | 35.19% | 25.44% | 26.45% |
|
|
|||||
| Common Stock & APIC | 5.49% | 8.50% | 9.86% | 1.70% | 4.46% |
| Retained Earnings | -4.84% | -9.03% | -15.17% | -9.85% | -12.52% |
| Treasury Stock & Other | 288.47% | 289.15% | 1,947.48% | 1,451.82% | -- |
| Total Common Equity | 3.99% | -6.44% | -52.37% | -92.46% | -94.33% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.99% | -6.44% | -52.37% | -92.46% | -94.33% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 52.54% | 52.64% | -52.37% | -92.46% | -94.33% |
|
|
|||||